Skip to content

Clinical trials

Terminated Gastrointestinal Stromal Tumors trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Status: Terminated Clear all

31 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20041
20051
20073
20084
20095
20101
20112
20141
20152
20173
20181
20192
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated31

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)5
Stanford University3
Daiichi Sankyo2
Novartis Pharmaceuticals2
AB Science1
Columbia University1
Eli Lilly and Company1
European Organisation for Research and Treatment of Cancer - EORTC1
Fox Chase Cancer Center1
Infinity Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors31
Stomach Neoplasms5
Carcinoma, Hepatocellular3
Carcinoma, Non-Small-Cell Lung3
Gastrointestinal Neoplasms3
Bile Duct Neoplasms2
Colonic Neoplasms2
Colorectal Neoplasms2
Esophageal Neoplasms2
Gallbladder Neoplasms2

Trials

Showing 51 to 31 of 31. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.